Delivery Order SPE2DB20D1100-SPE2DB25FA8B6
Award Date 2/27/25
Potential Completion Date 3/20/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,421.76 firm-fixed-price contract is for the supply of RYANODEX 250 MG VIALS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and was awarded on February 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $3,210.88 and a performance period through July 9, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,448.96, is for the supply of RYANODEX 250MG VIAL 1S, a medical product. The contract is a firm fixed-price delivery order with a performance period ending on May 14, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a ceiling value of $16,054.40 and a completion date of July 30, 2025. The contract is a firm fixed price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a potential value of $2,979.28 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of RYANODEX 250 MG VIALS, a medication, with a ceiling value of $1,489.64 and a completion date of September 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables...
- This is a $3,210.88 Firm Fixed Price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on June 25, 2025. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a period of performance through July 17, 2025. The contract is not set aside and was awarded under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The order is for 4,565,338,781 units of the pharmaceutical product RYANODEX 250 MG VIALS, with a ceiling value of $2,979.28. The contract is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This is a delivery order awarded to AmerisourceBergen Drug Corp Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has a firm-fixed price ceiling value of $22,344.60 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a potential value of $1,489.64 and a completion date of March 14, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December...